Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Armata Pharmaceuticals Inc. buy mixitrader

Start price
08.01.22 / 50%
Target price
Performance (%)
End price
This prediction ended on 22.01.22 with a price of €4.18. With a performance of -7.52%, the BUY prediction by mixitrader finished with a loss. mixitrader has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Armata Pharmaceuticals Inc. -1.942% -1.942%
iShares Core DAX® 0.521% 5.643%
iShares Nasdaq 100 -0.380% 8.955%
iShares Nikkei 225® -0.343% 4.576%
iShares S&P 500 0.037% 6.714%

According to mixitrader what are the pros and cons of Armata Pharmaceuticals Inc. for the foreseeable future?

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model

Comments by mixitrader for this prediction

In the thread Armata Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -7.52%
Target price 10.000
Ends at

Buy mit Kursziel 10,0

In the thread Trading Armata Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -7.52%
Target price 10.000
Ends at 08.01.23

Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.